Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin in TKA Patients With Central Sensitization
NCT05460871Phase 4Terminated
- Sponsor
- University of Iowa
- Start
- Feb 2023
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pregabalin in Central sensitization (CS), postoperative pain, sponsored by University of Iowa. Started Feb 2023; status: terminated.
02
Drugs
pregabalin
03
Conditions
Central sensitization (CS)postoperative pain
Beyond the preview
Go deeper on NCT05460871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05460871.